We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Revealed! The most sold FTSE 100 stocks by Hargreaves Lansdown investors

Demand for these FTSE 100 stocks sank among Hargreaves Lansdown clients this year. But could they rebound in 2023?

| More on:
Middle-aged white man pulling an aggrieved face while looking at a screen

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 index of stocks has performed more resolutely than many other major share bourses in 2022. But investor appetite hasn’t been robust across the Footsie.

In fact, the following FTSE index shares were the most sold of all UK and UK stocks — as well as investment trusts and exchange-traded funds — by Hargreaves Lansdown investors this year.

XXX

Here are the British stocks which experienced the highest number of net sells in 2022.

The wrong medicine

Unfashionable AstraZeneca’s (LSE: AZN) share price has endured a “volatile” time in 2022, Hargreaves Lansdown comments.

It says that “research and development is the engine of Astra’s long-term growth, and although it’s enjoyed a string of major approvals this year, this is a risky endeavour and there are no guarantees of Astra’s success”.

Drugs development is a highly unpredictable business. Problems at the R&D stage can result in enormous profits-sapping extra costs. Earnings forecasts can be left in tatters too if a drug in a fast-growing treatment area fails to get past regulators.

But AstraZeneca has a great track record of success in the laboratory. That’s why it had a colossal market-cap north of £175bn. In December alone, it received a string of approvals from the EU for various cancer and cardiovascular drugs.

Banking stock falls

HSBC has also been heavily sold by Hargreaves Lansdown customers in 2022. The share price here has been extremely choppy throughout 2022 as investors have reacted to the ongoing Covid-19 crisis in China.

The bank sources the lion’s share of profits from Asia. So worries over the Chinese economy — and the knock-on effect of slowing growth on the rest of the region — have climbed this year. Concerns over the country’s real estate sector have also sapped investor confidence.

The easing of lockdown restrictions in China might help HSBC’s profits recover looking ahead however. The Asian banking market is tipped for strong long-term growth as wealth levels there balloon.

Tech troubles

Meanwhile, Hargreaves Lansdown notes that “the trials of big tech this year is also showing up in investor behaviour with the tech heavy Scottish Mortgage Investment Trust”.

This FTSE 100 share has suffered as worries over tech-focused growth stocks have grown. Its core holdings include semiconductor manufacturing equipment supplier ASML, electric vehicle (EV) manufacturer Tesla and online retail giant Amazon.

Scottish Investment’s share price slipped sunk 44% in 2022. However, a shallower-than-expected economic slowdown next year could help it recover ground.

Oil stocks slip

Oil majors BP and Shell were also among the most highly sold on Hargreaves Lansdown’s investment platform this year.

The firm said that “sky-high oil and gas prices kept the cash pouring in” in 2022. But it added that cautious investors have been booking profits following recent share price gains, noting that “profits will pump less vigorously in 2023”.

The ongoing war in Ukraine could support oil prices next year. So could continued production cuts by influential OPEC+ countries.

However, profits at Shell and BP might fall off a cliff as the global economy slows and oil demand weakens. The rise of renewable energy poses a significant risk in 2023 and beyond too.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended ASML, Amazon.com, HSBC Holdings, Hargreaves Lansdown Plc, and Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »